Cause-specific mortality according to urine albumin creatinine ratio in the general population

PLoS ONE

Volumn 9, Issue 3, 2014, Pages

  Skaaby, Tea ^a   Husemoen, Lise Lotte Nystrup ^a   Ahluwalia, Tarunveer Singh ^b   Rossing, Peter ^b,c,d   Jørgensen, Torben ^a,e,f   Thuesen, Betina Heinsbæk ^a   Pisinger, Charlotta ^a   Rasmussen, Knud ^g   Linneberg, Allan ^a,e  

^a GLOSTRUP UNIVERSITY HOSPITAL   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c STENO DIABETES CENTER   (Denmark)

^d AARHUS UNIVERSITY   (Denmark)

^e UNIVERSITY OF COPENHAGEN   (Denmark)

^f AALBORG UNIVERSITY   (Denmark)

^g ROSKILDE HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; CREATININE;

ADULT; ALBUMINURIA; ARTICLE; BEHAVIOR DISORDER; CARDIOVASCULAR DISEASE; CREATININE BLOOD LEVEL; CREATININE URINE LEVEL; DENMARK; ENDOCRINE DISEASE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; METABOLIC DISORDER; MORTALITY; NUTRITIONAL DISORDER; RENAL SYSTEM PARAMETERS; RESPIRATORY TRACT DISEASE; URINE ALBUMIN CREATININE RATIO; CAUSE OF DEATH; DIABETES MELLITUS; FOLLOW UP; HEALTH SURVEY; MIDDLE AGED; PROPORTIONAL HAZARDS MODEL; REGISTER; RISK FACTOR; URINE;

ADULT; ALBUMINURIA; CARDIOVASCULAR DISEASES; CAUSE OF DEATH; CREATININE; DENMARK; DIABETES MELLITUS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; POPULATION SURVEILLANCE; PROPORTIONAL HAZARDS MODELS; REGISTRIES; RISK FACTORS;

EID: 84899849211     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0093212     Document Type: Article

References (36)

1. Cox AJ, Hsu FC, Carr JJ, Freedman BI, Bowden DW (2013) Glomerular filtration rate and albuminuria predict mortality independently from coronary artery calcified plaque in the Diabetes Heart Study. Cardiovasc Diabetol 12: 68.
2. Mahmoodi BK, Matsushita K, Woodward M, Blankestijn PJ, Cirillo M, et al. (2012) Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without hypertension: a meta-analysis. Lancet 380: 1649-61.
3. Matsushita K, van d, V, Astor BC, Woodward M, Levey AS, et al. (2010) Association of estimated glomerular filtration rate and albuminuria with allcause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. Lancet 375: 2073-81.
4. Kovesdy CP, Lott EH, Lu JL, Malakauskas SM, Ma JZ, et al. (2013) Outcomes associated with microalbuminuria: effect modification by chronic kidney disease. J Am Coll Cardiol 61: 1626-33.
5. van d, V, Matsushita K, Coresh J, Astor BC, Woodward M, et al. (2011) Lower estimated glomerular filtration rate and higher albuminuria are associated with all-cause and cardiovascular mortality. A collaborative meta-analysis of high-risk population cohorts. Kidney Int 79: 1341-52.
6. Gansevoort RT, Matsushita K, van d V, Astor BC, Woodward M, et al. (2011) Lower estimated GFR and higher albuminuria are associated with adverse kidney outcomes. A collaborative meta-analysis of general and high-risk population cohorts. Kidney Int 80: 93-104.
7. Fox CS, Matsushita K, Woodward M, Bilo HJ, Chalmers J, et al. (2012) Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without diabetes: a meta-analysis. Lancet 380: 1662-73.
8. Astor BC, Matsushita K, Gansevoort RT, van d, V, Woodward M, et al. (2011) Lower estimated glomerular filtration rate and higher albuminuria are associated with mortality and end-stage renal disease. A collaborative meta-analysis of kidney disease population cohorts. Kidney Int 79: 1331-40.
9. Ruggenenti P, Porrini E, Motterlini N, Perna A, Ilieva AP, et al. (2012) Measurable Urinary Albumin Predicts Cardiovascular Risk among Normoalbuminuric Patients with Type 2 Diabetes. J Am Soc Nephrol.
10. Aguilar MI, O'Meara ES, Seliger S, Longstreth WT Jr, Hart RG, et al. (2010) Albuminuria and the risk of incident stroke and stroke types in older adults. Neurology 75: 1343-50.
11. Bulcun E, Ekici M, Ekici A, Kisa U (2013) Microalbuminuria in chronic obstructive pulmonary disease. COPD 10: 186-92.
12. Fried L (2012) Albuminuria and cognitive impairment. Clin J Am Soc Nephrol 7: 376-8.
13. de ZD, Remuzzi G, Parving HH, Keane WF, Zhang Z, et al. (2004) Albuminuria, a therapeutic target for cardiovascular protection in type 2 diabetic patients with nephropathy. Circulation 110: 921-7.
14. Ibsen H, Olsen MH, Wachtell K, Borch-Johnsen K, Lindholm LH, et al. (2008) Reduction in albuminuria translates to reduction in cardiovascular events in hypertensive patients with left ventricular hypertrophy and diabetes. J Nephrol 21: 566-9.
15. Olsen MH, Hansen TW, Christensen MK, Gustafsson F, Rasmussen S, et al. (2007) N-terminal pro-brain natriuretic peptide, but not high sensitivity Creactive protein, improves cardiovascular risk prediction in the general population. Eur Heart J 28: 1374-81. (Pubitemid 47355969)
16. Jorgensen T, Borch-Johnsen K, Thomsen TF, Ibsen H, Glumer C, et al. (2003) A randomized non-pharmacological intervention study for prevention of ischaemic heart disease: baseline results Inter99. Eur J Cardiovasc Prev Rehabil 10: 377-86. (Pubitemid 38037253)
17. Olsen MH, Hansen TW, Christensen MK, Gustafsson F, Rasmussen S, et al. (2005) N-terminal pro brain natriuretic peptide is inversely related to metabolic cardiovascular risk factors and the metabolic syndrome. Hypertension 46: 660-6. (Pubitemid 43186736)
18. Aadahl M, von Huth SL, Pisinger C, Toft UN, Glumer C, et al. (2009) Five-year change in physical activity is associated with changes in cardiovascular disease risk factors: the Inter99 study. Prev Med 48: 326-31.
19. Ambye L, Rasmussen S, Fenger M, Jorgensen T, Borch-Johnsen K, et al. (2005) Studies of the Gly482Ser polymorphism of the peroxisome proliferator-activated receptor gamma coactivator 1alpha (PGC-1alpha) gene in Danish subjects with the metabolic syndrome. Diabetes Res Clin Pract 67: 175-9. (Pubitemid 40093028)
20. Thyssen JP, Linneberg A, Carlsen BC, Johansen JD, Engkilde K, et al. (2011) A possible association between a dysfunctional skin barrier (filaggrin null-mutation status) and diabetes: a cross-sectional study. BMJ Open 1: e000062.
21. Friedrich N, Thuesen B, Jorgensen T, Juul A, Spielhagen C, et al. (2012) The association between IGF-I and insulin resistance: a general population study in Danish adults. Diabetes Care 35: 768-73.
22. Juel K, Helweg-Larsen K (1999) The Danish registers of causes of death. Dan Med Bull 46: 354-7. (Pubitemid 29439149)
23. Wang CC, Reusch JE (2012) Diabetes and cardiovascular disease: changing the focus from glycemic control to improving long-term survival. Am J Cardiol 110: 58B-68B.
24. Casanova C, de Torres JP, Navarro J, Aguirre-Jaime A, Toledo P, et al. (2010) Microalbuminuria and hypoxemia in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 182: 1004-10.
25. Sajjad I, Grodstein F, Kang JH, Curhan GC, Lin J (2012) Kidney dysfunction and cognitive decline in women. Clin J Am Soc Nephrol 7: 437-43.
26. Sajjad I, Grodstein F, Kang JH, Curhan GC, Lin J (2012) Kidney dysfunction and cognitive decline in women. Clin J Am Soc Nephrol 7: 437-43.
27. Witte EC, Lambers Heerspink HJ, de ZD, Bakker SJ, de Jong PE, et al. (2009) First morning voids are more reliable than spot urine samples to assess microalbuminuria. J Am Soc Nephrol 20: 436-43.
28. Babazono T, Takahashi C, Iwamoto Y (2004) Definition of microalbuminuria in first-morning and random spot urine in diabetic patients. Diabetes Care 27: 1838-9. (Pubitemid 38857475)
29. Martin H (2011) Laboratory measurement of urine albumin and urine total protein in screening for proteinuria in chronic kidney disease. Clin Biochem Rev 32: 97-102.
30. Selvin E, Juraschek SP, Eckfeldt J, Levey AS, Inker LA, et al. (2013) Within-person variability in kidney measures. Am J Kidney Dis 61: 716-22.
31. Drivsholm T, Ibsen H, Schroll M, Davidsen M, Borch-Johnsen K (2001) Increasing prevalence of diabetes mellitus and impaired glucose tolerance among 60-year-old Danes. Diabet Med 18: 126-32. (Pubitemid 32238958)
32. de Borst MH, Hajhosseiny R, Tamez H, Wenger J, Thadhani R, et al. (2013) Active Vitamin D Treatment for Reduction of Residual Proteinuria: A Systematic Review. J Am Soc Nephrol.
33. Ruggenenti P, Fassi A, Ilieva AP, Bruno S, Iliev IP, et al. (2004) Preventing microalbuminuria in type 2 diabetes. N Engl J Med 351: 1941-51. (Pubitemid 39447135)
34. Menne J, Izzo JL Jr, Ito S, Januszewicz A, Katayama S, et al. (2012) Prevention of microalbuminuria in patients with type 2 diabetes and hypertension. J Hypertens 30: 811-8.
35. Haller H, Ito S, Izzo JL Jr, Januszewicz A, Katayama S, et al. (2011) Olmesartan for the delay or prevention of microalbuminuria in type 2 diabetes. N Engl J Med 364: 907-17.
36. Han T, Rong G, Quan D, Shu Y, Liang Z, et al. (2013) Meta-analysis: the efficacy and safety of paricalcitol for the treatment of secondary hyperparathyroidism and proteinuria in chronic kidney disease. Biomed Res Int 2013: 320560.